Rankings
▼
Calendar
BBOT Q1 2024 Earnings — BridgeBio Oncology Therapeutics Inc. Revenue & Financial Results | Market Cap Arena
BBOT
BridgeBio Oncology Therapeutics Inc.
$820M
Q1 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$15M
Net Income
-$15M
EPS (Diluted)
$0.05
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$9M
Free Cash Flow
-$9M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$188M
Total Liabilities
$6M
Stockholders' Equity
$182M
Cash & Equivalents
$2M
← FY 2024
All Quarters
Q2 2024 →
